Wyden, Hatch, Markey Applaud Congressional Passage of Access to Clinical Trials Bill

WASHINGTON –Senate Finance Committee Ranking Member Ron Wyden, D-Ore., Senate Finance Committee Chairman Orrin Hatch, R-Utah, and Senator Edward J. Markey, D-Mass., today applauded the House of Representatives’ passage of the “Ensuring Access to Clinical Trials Act,” bipartisan legislation that makes it possible for people receiving Supplemental Security Income (SSI) and Medicaid to continue participating […]

Wyden Statement on the Social Security Disability Insurance Trust Fund

I want to take a few minutes today to discuss the enormous importance of America’s most critical safety net program — Social Security. In particular, I want to talk about the Social Security Disability Insurance program and introduce a proposal to secure the financing of Social Security. Of all the strands woven together in America’s […]

Wyden Offers Support for Proposed Biosimilar Drug Payment Rule from CMS

WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today sent a letter to the Centers for Medicare and Medicaid Services (CMS) offering support for their proposed rule on paying for biosimilar biological products (biosimilars): “Biosimilar products should compete with one another – rather than set their own price – to ensure patients have […]

Wyden Welcomes Release of Summaries of U.S. Negotiating Objectives for Pacific Trade Agreement

WASHINGTON –Sen. Ron Wyden, ranking Democrat on the Senate Finance Committee, welcomed the U.S. Trade Representative’s (USTR) release of new summaries of negotiating objectives in the Trans-Pacific Partnership. These summaries were required under the Trade Promotion Authority (TPA) bill Wyden co-authored, which became law earlier this year.  “I’ve said it for years – if you […]

Wyden Highlights GAO Report Showing E-Cigarettes Do Not Lower Smoking Rates

While E-Cigarette Use Spikes Among Teens and Others, Conventional Smoking Rates Appear Unaffected E-Cigs Are Currently Exempt from Federal Excise Tax and Age Limits; No Regulations on Ingredients, Flavors, or Advertising Despite Wyden’s Calls for Increased Transparency, Still Virtually No Oversight of Health Effects or Imports from China WASHINGTON–Senate Finance Committee Ranking Member Ron Wyden, […]

Wyden Praises Announcement of Tim Reif as USTR Chief Transparency Officer

WASHINGTON – SenateFinance Committee Ranking Member Ron Wyden, D-Ore., today praised the announcement of Tim Reif as Chief Transparency Officer at the Office of U.S. Trade Representative (USTR). Wyden successfully fought to create the new post as part of the Bipartisan Trade Prioritization and Accountability Act, which he co-authored. “This announcement is a good move […]

Wyden Cautions IRS Resource Cuts Could Fuel Tax Evasion, Data Theft

WASHINGTON –Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today sent a letter to IRS Commissioner John Koskinen asking how deep cuts made by Congress to IRS resources over the last several years could hamper the agency’s ability to crack down on tax cheats — and fuel cyberattacks against taxpayer data. “Cutting enforcement spending, such […]

Wyden, Casey Call for GAO Report Into Federal Government’s Nursing Home Rating System

Washington DC- Today, U.S. Senators Bob Casey (D-PA) and Ron Wyden (D-OR) called for an GAO Report on the federal government’s nursing home rating system. Recent news reports have raised questions about the integrity of the federal government’s ‘Five-Star’ rating system that millions of families rely on when selecting a nursing home for their loved […]